Welcome to our dedicated page for Liveworld news (Ticker: LVWD), a resource for investors and traders seeking the latest updates and insights on Liveworld stock.
LiveWorld reports news on its business as a human-led, AI-powered digital marketing agency and software company serving healthcare, pharmaceutical and other regulated brands. Company updates focus on social and digital media compliance, expert-led moderation, community engagement, AI-powered insights, and software-enabled customer experience programs.
Recurring developments include financial results, investment in AI-based products, healthcare-ready search optimization services spanning GEO, AIO and SEO, and AI Brand Reputation Index research for pharmaceutical and OTC consumer healthcare brands. LiveWorld’s disclosures also describe how its offerings combine human review, regulatory expertise and AI tools for brand engagement and reputation intelligence.
LiveWorld (OTC Markets: LVWD) has partnered with Mount Sinai Health System to launch a unique online community for caregivers of dementia patients called “Navigating Dementia.” This initiative responds to the growing need for emotional and clinical support, as dementia cases are projected to reach nearly 80 million by 2030. The community quickly gained 600 members in its first 90 days, with high engagement levels, indicating a strong demand for healthcare networks.
This collaboration aims to improve healthcare outcomes and brand perception through shared caregiver experiences and supported insights.
LiveWorld, Inc. (OTC-PINK: LVWD) announces new services to enhance hospital marketing in response to digital and social media transformation. With 25 years in healthcare, the agency offers expertise in acquiring and connecting with patients. CEO Peter Friedman emphasizes that traditional marketing is failing amidst this shift. LiveWorld's services include campaign strategy, creative production, social media marketing, and community management, aiding hospitals in adapting to new economic and consumer-centric challenges.
LiveWorld, Inc. (OTC Markets: LVWD) reported second quarter 2021 revenues of approximately $2.5 million, an 18% increase from $2.1 million in Q2 2020. For the first half of 2021, revenues rose to approximately $4.7 million from $4.0 million year-over-year, with healthcare-related revenues growing 26%. The net income for Q2 2021 was about $130,000, up from $28,000 in Q2 2020, while the six-month net income reached $251,000 compared to a net loss of $61,000 in the previous year. As of June 30, 2021, the company held approximately $3.3 million in cash and equivalents, up from $2.6 million at 2020's end.
LiveWorld, Inc. (OTC Markets: LVWD) has launched a new dedicated Healthcare Professional (HCP) Social Media practice aimed at enhancing engagement with healthcare providers. This initiative, led by VP Strategy Danny Flamberg and Medical Director Umar Siddiqui, MD, responds to the increasing use of social media among physicians. According to QuantiaMD, 80% of surveyed physicians utilize social media for their practice. LiveWorld's expertise positions it to help pharmaceutical brands effectively communicate and promote their innovations through strategic social media engagement.
LiveWorld, Inc. (OTC Markets: LVWD) has announced its financial results for Q1 2021, reporting total revenues of approximately $2.2 million, up 17% from $1.9 million in Q1 2020. Healthcare-related revenues rose by 24% during this period. The company achieved a net income of approximately $121,000, compared to a net loss of $89,000 in the previous year, signaling improved profitability. Cash from operations also increased to $1.2 million, reflecting a 157% boost. Despite a reduction in cash and equivalents due to higher accounts receivable, the company remains focused on expanding digital services and maintaining profitability.
LiveWorld, Inc. (OTC Markets: LVWD) announced the appointment of Dr. Umar Siddiqui as Medical Director, reporting to Chairman & CEO Peter Friedman. This strategic addition underscores the company's commitment to enhancing digital and social media marketing expertise in biopharma, life sciences, and healthcare. Dr. Siddiqui brings over 15 years of experience in clinical research, health-system leadership, and digital health technology, having previously collaborated with PwC and Merck. His background is expected to strengthen LiveWorld's capabilities in providing innovative customer engagement solutions.